Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Next Previous
X
Search
Trial Profile

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 Mar 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tazarotene/ulobetasol (Primary) ; Tazarotene; Ulobetasol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Bausch Health Companies; Valeant Pharmaceuticals International

    • Most Recent Events

    • 04 Mar 2020 Systematic review assessing phase II and phase III clinical trial data (NCT02045277, NCT02785172, NCT02462070, NCT02462122 and NCT02462083) pertaining to efficacy and safety of HP/TAZ combinational topical therapy published in the Annals of Pharmacotherapy
    • 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
    • 08 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top